Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 25, which means every article in Journal of Pharmacovigilance has got 25 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacovigilance.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Total published articles

37 57 61 61 17 5 26 31 56 62 50 30

Research, Review articles and Editorials

0 1 8 27 11 5 16 25 46 45 36 26

Research communications, Review communications, Editorial communications, Case reports and Commentary

31 56 53 34 6 0 10 6 10 17 14 4

Conference proceedings

0 7 0 0 0 0 30 50 94 70 201 73

Citations received as per Google Scholar, other indexing platforms and portals

151 216 237 311 270 254 238 198 319 91 48 18
Journal total citations count 2408
Journal impact factor 1.71
Journal 5 years impact factor 1.79
Journal cite score 12.14
Journal h-index 25
Important citations

Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization

A Large-Scale CNN Ensemble for Medication Safety Analysis

Dependency-based long short term memory network for drug-drug interaction extraction

Drug-drug interaction extraction from biomedical texts using long short-term memory network

Application of Novel Genotyping Microarray Technologies in Cancer Research

A Survey of Network-Based Modelling and Intelligent Data Mining of Social Media for Improving Care

Adverse Drug Event Information Extraction from Medical Narratives using Ensemble Learning & Deep Learning

Novel Antitumor Benefit of Metformin: Beyond Glycemic Control

Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm

The pivotal relation between glucagon-like peptides, NF?B and inflammatory bowel disease

Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives

Multi-layered Learning for Information Extraction from Adverse Drug Event Narratives

Cardiovascular outcome trials in type 2 diabetes: A critical analysis

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

One Size Does Not Fit All: An Ensemble Approach Towards Information Extraction from Adverse Drug Event Narratives

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus

The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis

Adverse Effects of GLP-1 Receptor Agonists

Antidiabetic Activity and Pharmacodynamic Interaction of Combined Administration of Ethanolic Stem Bark Extract of Enantia Chlorantha and Lisinopril in Type 2 Diabetic Rats

Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study